ACR DSI shares list of FDA-cleared AI algorithms for medical imaging

The American College of Radiology (ACR) Data Science Institute (DSI) has created a new resource for radiology researchers: a full list of FDA-cleared AI algorithms related to medical imaging.  

The list includes a wide range of AI models and was designed to save researchers valuable time. The list includes a summary of each algorithm’s manufacturer, intended purpose, FDA product area and more.

“Models range from detecting pneumothorax in chest X-rays to highlighting segments of the brain on MRI,” according to a statement from the ACR. “Several models may increase efficiency by detecting positive findings on images and notifying the radiologist of the suspected findings for further action.”

The full list, published on the ACR DSI website, will be updated regularly.

Michael Walter
Michael Walter, Managing Editor

Michael has more than 18 years of experience as a professional writer and editor. He has written at length about cardiology, radiology, artificial intelligence and other key healthcare topics.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.